Chinese General Practice ›› 2024, Vol. 27 ›› Issue (07): 810-815.DOI: 10.12114/j.issn.1007-9572.2023.0343
Special Issue: 心血管最新文章合辑; 老年人群健康最新文章合辑
• Article • Previous Articles Next Articles
Received:
2023-06-14
Revised:
2023-09-11
Published:
2024-03-05
Online:
2023-12-19
Contact:
PENG Derong
通讯作者:
彭德荣
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0343
指标 | 低危组(n=5 930) | 中危组(n=1 804) | 高危组(n=2 085) | χ2值 | P值 | 趋势性检验P值 |
---|---|---|---|---|---|---|
年龄 | 1 236.557 | <0.001 | <0.001 | |||
30~岁 | 561(9.5) | 4(0.2) | 36(1.7) | |||
40~岁 | 1 251(21.1) | 52(2.9) | 108(5.2) | |||
50~岁 | 1 522(25.7) | 342(19.0) | 454(21.8) | |||
60~岁 | 2 280(38.4) | 1 180(65.4) | 1 183(56.7) | |||
70~岁 | 316(5.3) | 226(12.5) | 304(14.6) | |||
男性 | 2 495(42.1) | 696(38.6) | 1 185(56.8) | 168.092 | <0.001 | <0.001 |
高中及以上学历 | 2 615(44.1) | 438(24.3) | 645(30.9) | 282.417 | <0.001 | <0.001 |
超重或肥胖 | 2 537(42.8) | 1 032(57.2) | 1 338(64.2) | 328.555 | <0.001 | <0.001 |
吸烟 | 881(14.9) | 303(16.8) | 742(35.6) | 431.602 | <0.001 | <0.001 |
饮酒 | 1 200(20.2) | 378(21.0) | 563(27.0) | 42.361 | <0.001 | <0.001 |
糖尿病 | 601(10.1) | 302(16.7) | 1 247(59.8) | 2 260.015 | <0.001 | <0.001 |
高血压 | 1 177(19.7) | 1 595(88.4) | 1 656(79.4) | 3 899.516 | <0.001 | <0.001 |
高三酰甘油血症 | 442(7.5) | 193(10.7) | 426(20.4) | 269.607 | <0.001 | <0.001 |
高总胆固醇血症 | 120(2.0) | 206(11.4) | 284(13.6) | 458.931 | <0.001 | <0.001 |
高低密度脂蛋白胆固醇血症 | 153(2.6) | 160(8.9) | 165(7.9) | 171.151 | <0.001 | <0.001 |
低高密度脂蛋白胆固醇血症 | 1 076(18.1) | 294(16.3) | 815(39.1) | 436.416 | <0.001 | <0.001 |
打鼾频率 | 110.051 | <0.001 | <0.001 | |||
不打鼾 | 4 640(78.2) | 1 237(68.6) | 1 406(67.4) | |||
轻度打鼾 | 668(11.3) | 307(17.0) | 354(17.0) | |||
中度打鼾 | 418(7.0) | 171(9.5) | 211(10.1) | |||
重度打鼾 | 204(3.4) | 89(4.9) | 114(5.5) |
Table 1 Correlation analysis of 10-year risk of ASCVD in middle-aged and elderly population in Shanghai
指标 | 低危组(n=5 930) | 中危组(n=1 804) | 高危组(n=2 085) | χ2值 | P值 | 趋势性检验P值 |
---|---|---|---|---|---|---|
年龄 | 1 236.557 | <0.001 | <0.001 | |||
30~岁 | 561(9.5) | 4(0.2) | 36(1.7) | |||
40~岁 | 1 251(21.1) | 52(2.9) | 108(5.2) | |||
50~岁 | 1 522(25.7) | 342(19.0) | 454(21.8) | |||
60~岁 | 2 280(38.4) | 1 180(65.4) | 1 183(56.7) | |||
70~岁 | 316(5.3) | 226(12.5) | 304(14.6) | |||
男性 | 2 495(42.1) | 696(38.6) | 1 185(56.8) | 168.092 | <0.001 | <0.001 |
高中及以上学历 | 2 615(44.1) | 438(24.3) | 645(30.9) | 282.417 | <0.001 | <0.001 |
超重或肥胖 | 2 537(42.8) | 1 032(57.2) | 1 338(64.2) | 328.555 | <0.001 | <0.001 |
吸烟 | 881(14.9) | 303(16.8) | 742(35.6) | 431.602 | <0.001 | <0.001 |
饮酒 | 1 200(20.2) | 378(21.0) | 563(27.0) | 42.361 | <0.001 | <0.001 |
糖尿病 | 601(10.1) | 302(16.7) | 1 247(59.8) | 2 260.015 | <0.001 | <0.001 |
高血压 | 1 177(19.7) | 1 595(88.4) | 1 656(79.4) | 3 899.516 | <0.001 | <0.001 |
高三酰甘油血症 | 442(7.5) | 193(10.7) | 426(20.4) | 269.607 | <0.001 | <0.001 |
高总胆固醇血症 | 120(2.0) | 206(11.4) | 284(13.6) | 458.931 | <0.001 | <0.001 |
高低密度脂蛋白胆固醇血症 | 153(2.6) | 160(8.9) | 165(7.9) | 171.151 | <0.001 | <0.001 |
低高密度脂蛋白胆固醇血症 | 1 076(18.1) | 294(16.3) | 815(39.1) | 436.416 | <0.001 | <0.001 |
打鼾频率 | 110.051 | <0.001 | <0.001 | |||
不打鼾 | 4 640(78.2) | 1 237(68.6) | 1 406(67.4) | |||
轻度打鼾 | 668(11.3) | 307(17.0) | 354(17.0) | |||
中度打鼾 | 418(7.0) | 171(9.5) | 211(10.1) | |||
重度打鼾 | 204(3.4) | 89(4.9) | 114(5.5) |
变量 | 赋值 |
---|---|
年龄 | 30~岁=1,40~岁=2,50~岁=3,60~岁=4,70~岁=5 |
性别 | 女=0,男=1 |
高血压 | 否=0,是=1 |
糖尿病 | 否=0,是=1 |
超重或肥胖 | 否=0,是=1 |
饮酒 | 否=0,是=1 |
高中及以上学历 | 否=0,是=1 |
吸烟 | 否=0,是=1 |
打鼾频率 | 不打鼾=0,轻度打鼾=1,中度打鼾=2,重度打鼾=3 |
ASCVD 10年发病风险 | 低危=1,中危=2,高危=3 |
高三酰甘油血症 | 否=0,是=1 |
高总胆固醇血症 | 否=0,是=1 |
高低密度脂蛋白胆固醇血症 | 否=0,是=1 |
低高密度脂蛋白胆固醇血症 | 否=0,是=1 |
Table 2 Variable assignment
变量 | 赋值 |
---|---|
年龄 | 30~岁=1,40~岁=2,50~岁=3,60~岁=4,70~岁=5 |
性别 | 女=0,男=1 |
高血压 | 否=0,是=1 |
糖尿病 | 否=0,是=1 |
超重或肥胖 | 否=0,是=1 |
饮酒 | 否=0,是=1 |
高中及以上学历 | 否=0,是=1 |
吸烟 | 否=0,是=1 |
打鼾频率 | 不打鼾=0,轻度打鼾=1,中度打鼾=2,重度打鼾=3 |
ASCVD 10年发病风险 | 低危=1,中危=2,高危=3 |
高三酰甘油血症 | 否=0,是=1 |
高总胆固醇血症 | 否=0,是=1 |
高低密度脂蛋白胆固醇血症 | 否=0,是=1 |
低高密度脂蛋白胆固醇血症 | 否=0,是=1 |
项目 | 模型一 | 模型二 | 模型三 | ||||||
---|---|---|---|---|---|---|---|---|---|
Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | |
男性 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.333 | 0.563 | 1.24(0.87~1.76) | 0.656 | 0.418 | 1.27(0.89~1.80) | 2.097 | 0.148 | 1.40(0.94~2.08) |
中度打鼾 | 11.791 | 0.001 | 1.45(1.17~1.78) | 5.151 | 0.023 | 1.28(1.03~1.58) | 0.020 | 0.889 | 1.10(0.98~1.82) |
重度打鼾 | 68.246 | <0.001 | 1.96(1.67~2.30) | 56.513 | <0.001 | 1.94(1.65~2.29) | 6.567 | 0.010 | 1.28(1.05~1.56) |
女性 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.883 | 0.347 | 1.08(0.92~1.28) | 0.034 | 0.853 | 0.99(0.83~1.18) | 0.564 | 0.453 | 0.85(0.69~1.06) |
中度打鼾 | 10.168 | 0.001 | 1.48(1.15~1.89) | 4.258 | 0.039 | 1.31(1.07~1.60) | 3.969 | 0.056 | 1.08(0.92~1.28) |
重度打鼾 | 24.738 | <0.001 | 1.61(1.33~1.94) | 8.215 | 0.004 | 1.34(1.03~1.73) | 7.929 | 0.005 | 1.15(1.15~1.57) |
整体 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.784 | 0.356 | 1.36(0.99~1.86) | 2.348 | 0.137 | 1.33(0.95~1.53) | 3.073 | 0.080 | 1.18(0.83~1.35) |
中度打鼾 | 38.274 | <0.001 | 1.57(1.37~1.81) | 17.146 | <0.001 | 1.6(1.43~1.80) | 5.023 | 0.025 | 1.15(1.07~1.37) |
重度打鼾 | 41.685 | <0.001 | 1.71(1.41~2.07) | 27.068 | <0.001 | 1.63(1.35~1.99) | 9.741 | 0.002 | 1.50(1.19~1.88) |
Table 3 Logistic regression analysis of snoring frequency and risk of ASCVD in the next 10 years in middle-aged and elderly population in Shanghai
项目 | 模型一 | 模型二 | 模型三 | ||||||
---|---|---|---|---|---|---|---|---|---|
Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | |
男性 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.333 | 0.563 | 1.24(0.87~1.76) | 0.656 | 0.418 | 1.27(0.89~1.80) | 2.097 | 0.148 | 1.40(0.94~2.08) |
中度打鼾 | 11.791 | 0.001 | 1.45(1.17~1.78) | 5.151 | 0.023 | 1.28(1.03~1.58) | 0.020 | 0.889 | 1.10(0.98~1.82) |
重度打鼾 | 68.246 | <0.001 | 1.96(1.67~2.30) | 56.513 | <0.001 | 1.94(1.65~2.29) | 6.567 | 0.010 | 1.28(1.05~1.56) |
女性 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.883 | 0.347 | 1.08(0.92~1.28) | 0.034 | 0.853 | 0.99(0.83~1.18) | 0.564 | 0.453 | 0.85(0.69~1.06) |
中度打鼾 | 10.168 | 0.001 | 1.48(1.15~1.89) | 4.258 | 0.039 | 1.31(1.07~1.60) | 3.969 | 0.056 | 1.08(0.92~1.28) |
重度打鼾 | 24.738 | <0.001 | 1.61(1.33~1.94) | 8.215 | 0.004 | 1.34(1.03~1.73) | 7.929 | 0.005 | 1.15(1.15~1.57) |
整体 | |||||||||
不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
轻度打鼾 | 0.784 | 0.356 | 1.36(0.99~1.86) | 2.348 | 0.137 | 1.33(0.95~1.53) | 3.073 | 0.080 | 1.18(0.83~1.35) |
中度打鼾 | 38.274 | <0.001 | 1.57(1.37~1.81) | 17.146 | <0.001 | 1.6(1.43~1.80) | 5.023 | 0.025 | 1.15(1.07~1.37) |
重度打鼾 | 41.685 | <0.001 | 1.71(1.41~2.07) | 27.068 | <0.001 | 1.63(1.35~1.99) | 9.741 | 0.002 | 1.50(1.19~1.88) |
项目 | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|
高三酰甘油血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 0.174 | 0.677 | 0.67(0.59~1.12) |
中度打鼾 | 2.678 | 0.102 | 0.85(0.69~1.03) |
重度打鼾 | 7.197 | 0.007 | 1.32(1.07~1.64) |
高总胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 0.125 | 0.724 | 0.66(0.50~1.02) |
中度打鼾 | 3.060 | 0.080 | 1.21(0.83~1.77) |
重度打鼾 | 11.590 | 0.001 | 1.56(1.21~2.01) |
高低密度脂蛋白胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 4.416 | 0.065 | 0.88(0.66~1.18) |
中度打鼾 | 7.113 | 0.008 | 1.39(1.03~1.87) |
重度打鼾 | 8.561 | 0.033 | 1.49(1.01~2.21) |
低高密度脂蛋白胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 3.698 | 0.054 | 0.96(0.75~1.22) |
中度打鼾 | 8.561 | 0.003 | 1.26(1.06~1.49) |
重度打鼾 | 6.438 | 0.011 | 1.14(1.00~1.31) |
Table 4 Logistic regression analysis of the correlation between snoring frequency and ASCVD risk factors in middle-aged and elderly population in Shanghai
项目 | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|
高三酰甘油血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 0.174 | 0.677 | 0.67(0.59~1.12) |
中度打鼾 | 2.678 | 0.102 | 0.85(0.69~1.03) |
重度打鼾 | 7.197 | 0.007 | 1.32(1.07~1.64) |
高总胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 0.125 | 0.724 | 0.66(0.50~1.02) |
中度打鼾 | 3.060 | 0.080 | 1.21(0.83~1.77) |
重度打鼾 | 11.590 | 0.001 | 1.56(1.21~2.01) |
高低密度脂蛋白胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 4.416 | 0.065 | 0.88(0.66~1.18) |
中度打鼾 | 7.113 | 0.008 | 1.39(1.03~1.87) |
重度打鼾 | 8.561 | 0.033 | 1.49(1.01~2.21) |
低高密度脂蛋白胆固醇血症 | |||
不打鼾 | — | — | 1.00 |
轻度打鼾 | 3.698 | 0.054 | 0.96(0.75~1.22) |
中度打鼾 | 8.561 | 0.003 | 1.26(1.06~1.49) |
重度打鼾 | 6.438 | 0.011 | 1.14(1.00~1.31) |
[1] | |
[2] |
潘丽娜,高云,刘虹宏,等. 基于《中国心血管病预防指南2017》的中青年高血压患者ASCVD危险评估及分层分析[J]. 中国循证心血管医学杂志,2022,14(4):484-487. DOI:10.3969/j.issn.1674-4055.2022.04.25.
|
[3] |
|
[4] |
|
[5] |
谢开婿,王春梅,陈玲琍,等. 睡眠打鼾与浙江省成年人高血压患病关联的研究[J]. 中华流行病学杂志,2020,41(5):722-726. DOI:10.3760/cma.j.cn112338-20190814-00596.
|
[6] |
胡晶晶,乔鹏,赵佳,等. 上海市杨浦区居民打鼾与糖尿病的相关性调查研究[J]. 中国预防医学杂志,2021,22(1):37-42. DOI:10.16506/j.1009-6639.2021.01.008.
|
[7] |
|
[8] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志,2021,41(5):482-548.
|
[9] |
《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(1):1-44. DOI:10.3969/j.issn.1009-816X.2019.01.001.
|
[10] |
诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志,2016,31(10):937-953.
|
[11] |
|
[12] |
李岩. 北京社区居民打鼾与颈动脉粥样硬化关系的调查研究[J]. 中华疾病控制杂志,2013,17(8):702-705.
|
[13] |
孙海丽,秦彦文,魏永祥. 阻塞性睡眠呼吸暂停与动脉粥样硬化关系的研究进展[J]. 临床耳鼻咽喉头颈外科杂志,2020,34(10):958-960. DOI:10.13201/j.issn.2096-7993.2020.10.023.
|
[14] |
|
[15] |
刘玲娇,林燕,余湘尤,等. TG/HDL-c与职业人群ASCVD风险的相关性分析[J]. 重庆医学,2021,50(11):1891-1895. DOI:10.3969/j.issn.1671-8348.2021.11.021.
|
[16] |
|
[17] |
夏艳杰. 打鼾与心血管病及其代谢性危险因素的关系研究[D]. 北京:北京协和医学院,2019.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[1] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[2] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[3] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[4] | GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng. Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis [J]. Chinese General Practice, 2025, 28(21): 2697-2704. |
[5] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[6] | PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293. |
[7] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
[8] | ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu. Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021 [J]. Chinese General Practice, 2025, 28(18): 2253-2261. |
[9] | AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024. |
[10] | NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei. Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks [J]. Chinese General Practice, 2025, 28(15): 1847-1854. |
[11] | KONG Xiaoqian, WANG Jingyi, WANG Li, MAO Ting, XIA Wenjing, SHI Yan. The Real Experience of Elderly People in Rural Areas Who Witnessed Acute Cardiovascular and Cerebrovascular Events: a Qualitative Study [J]. Chinese General Practice, 2025, 28(11): 1342-1346. |
[12] | SUN Lin, SHI Yiwei, HOU Xiaomin, GUO Yunting, ZHAO Xu, DONG Lin, NIE Jisheng, QIN Xiaojiang. Relationship between Serum Sodium Levels and Length of Hospital Stay in Patients with Pulmonary Hypertension associated with Left Heart Disease [J]. Chinese General Practice, 2025, 28(09): 1065-1071. |
[13] | ZHENG Xiaomeng, ZHOU Xuan, SUN Yu, FAN Miao, JIN Yiyi, ZHU Suyan. Clinical Characteristics and Medication Patterns of Patients with Cardiometabolic Multimorbidity [J]. Chinese General Practice, 2025, 28(09): 1061-1064. |
[14] | GU Keyi, PAN Yaojia, HAN Zheng, FU Xiaoya, GU Handong, YANG Fei, WANG Weiqiang. Correlation between Different Obesity Metabolic Phenotypes and Atherosclerosis in a Young Population: Uric Acid as Its Potential Factor [J]. Chinese General Practice, 2025, 28(07): 831-837. |
[15] | WANG Yuan, XIAO Fei, ZHANG Yuxin, ZHOU Enhui, ZHONG Jianqin, HU Yuxin, HONG Feng. Relationship between Ethnic Minority Speciality Diets and Cardiovascular Disease: Based on the Cohort Study of Natural Populations Living in Ethnic Minority Aggregation Areas in the Southwest Region [J]. Chinese General Practice, 2025, 28(06): 688-696. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||